Status:
COMPLETED
Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Allergen Immunotherapy
Eligibility:
All Genders
5+ years
Brief Summary
Background : Allergen Immunotherapy (AIT) is the only etiological treatment for allergic respiratory diseases. In order to improve the competence on the use of AIT, it is important to extend the inves...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with IgE mediated respiratory allergy
- Patients who will initiate any type of aeroallergen AIT according to real life clinical standards of practice
- Any type of aeroallergen for AIT will be included : pollen, house dust mite, animal, dander, moulds
- Patient who is under the care of the Doctor participating in the survey
- Exclusion criteria:
- Patients who refuse to give their informed consent
- Food immunotherapy
- Venom Immunotherapy
Exclusion
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04038268
Start Date
September 1 2019
End Date
September 30 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295